210 related articles for article (PubMed ID: 32355535)
1. Combined signature of nine immune-related genes: a novel risk score for predicting prognosis in hepatocellular carcinoma.
Tang Y; Zeng Z; Wang J; Li G; Huang C; Dong X; Feng Z
Am J Transl Res; 2020; 12(4):1184-1202. PubMed ID: 32355535
[TBL] [Abstract][Full Text] [Related]
2. A novel risk score based on a combined signature of 10 immune system genes to predict bladder cancer prognosis.
Tang Y; Hu Y; Wang J; Zeng Z
Int Immunopharmacol; 2020 Oct; 87():106851. PubMed ID: 32763782
[TBL] [Abstract][Full Text] [Related]
3. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
4. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients.
Ye D; Liu Y; Li G; Sun B; Peng J; Xu Q
Front Oncol; 2021; 11():766072. PubMed ID: 34868990
[TBL] [Abstract][Full Text] [Related]
5. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration.
Long M; Zhou Z; Wei X; Lin Q; Qiu M; Zhou Y; Chen P; Jiang Y; Wen Q; Liu Y; Li R; Zhou X; Yu H
Front Immunol; 2022; 13():1023349. PubMed ID: 36353638
[TBL] [Abstract][Full Text] [Related]
6. A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma.
Yan Q; Zheng W; Wang B; Ye B; Luo H; Yang X; Zhang P; Wang X
BioData Min; 2021 May; 14(1):29. PubMed ID: 33962640
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma.
Chen W; Ou M; Tang D; Dai Y; Du W
J Immunol Res; 2020; 2020():5494858. PubMed ID: 32211443
[TBL] [Abstract][Full Text] [Related]
8. Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.
Qiu XT; Song YC; Liu J; Wang ZM; Niu X; He J
World J Gastrointest Oncol; 2020 Aug; 12(8):857-876. PubMed ID: 32879664
[TBL] [Abstract][Full Text] [Related]
9. A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma.
Zhang G; Su L; Lv X; Yang Q
Cancer Cell Int; 2021 Oct; 21(1):522. PubMed ID: 34627241
[TBL] [Abstract][Full Text] [Related]
10. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
Front Oncol; 2020; 10():541330. PubMed ID: 33072571
[No Abstract] [Full Text] [Related]
11. A novel immune signature to predict the prognosis of patients with hepatocellular carcinoma.
Li Q; Fan B; Ding J; Xiang X; Zhang J
Medicine (Baltimore); 2021 Aug; 100(33):e26948. PubMed ID: 34414957
[TBL] [Abstract][Full Text] [Related]
12. Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma.
Li Q; Jin L; Jin M
Front Genet; 2021; 12():613890. PubMed ID: 34194464
[TBL] [Abstract][Full Text] [Related]
13. A New Inflammation-Related Risk Model for Predicting Hepatocellular Carcinoma Prognosis.
Xing M; Li J
Biomed Res Int; 2022; 2022():5396128. PubMed ID: 35572724
[TBL] [Abstract][Full Text] [Related]
14. Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration.
Fu Y; He G; Liu Z; Wang J; Zhang Z; Bao Q; Wen J; Jin Z; Zhang W
J Inflamm Res; 2021; 14():6719-6734. PubMed ID: 34916821
[TBL] [Abstract][Full Text] [Related]
15. Systematic Construction and Validation of a Prognostic Model for Hepatocellular Carcinoma Based on Immune-Related Genes.
Yu J; Ma S; Tian S; Zhang M; Ding X; Liu Y; Yang F; Hu Y; Xuan G; Zhou X; Wang J; Han Y
Front Cell Dev Biol; 2021; 9():700553. PubMed ID: 34671598
[TBL] [Abstract][Full Text] [Related]
16. Establishment of an immune-related gene prognostic model for head and neck tumors.
Zhou F; Chen AX; Lv HY; Liang DH; Yu HS
J Biol Regul Homeost Agents; 2021; 35(3):975-986. PubMed ID: 34159769
[TBL] [Abstract][Full Text] [Related]
17. A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma.
Zhai WY; Duan FF; Chen S; Wang JY; Lin YB; Wang YZ; Rao BY; Zhao ZR; Long H
Front Genet; 2021; 12():798131. PubMed ID: 35069695
[TBL] [Abstract][Full Text] [Related]
18. An inflammation-related gene landscape predicts prognosis and response to immunotherapy in virus-associated hepatocellular carcinoma.
Gao YJ; Li SR; Huang Y
Front Oncol; 2023; 13():1118152. PubMed ID: 36969014
[TBL] [Abstract][Full Text] [Related]
19. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
Li W; Lu J; Ma Z; Zhao J; Liu J
Front Genet; 2019; 10():1323. PubMed ID: 32010188
[No Abstract] [Full Text] [Related]
20. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
